Verona Pharma Inc
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Pilot Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19 (NCT04527471) | Verona Pharma Inc | 2020-09-04 |
Track Verona Pharma Inc automatically
Every clearance here is in the API, with alerts when new ones post.